Loading insider details...
Latest Form 4 (Aug 24, 2026): Grant/Award of 657 NAVN shares, $18.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Navan, Inc. (NAVN) | Grant/Award | 657 | $18.8K |
| Aug 11, 2026 | Braveheart Bio, Inc. (BRVE) | Conversion | 9,132,420 | n/a |
| Jul 29, 2026 | Scribe Therapeutics, Inc. (SCTX) | Conversion | 2,051,742 | n/a |
| Jun 29, 2026 | Navan, Inc. (NAVN) | Grant/Award | 9,959 | n/a |
| Jun 4, 2026 | Nautilus Biotechnology, Inc. (NAUT) | Sale | 4,615,974 | $10.85M |
| May 22, 2026 | Navan, Inc. (NAVN) | Grant/Award | 1,012 | $18.8K |
| Jan 9, 2026 | Navan, Inc. (NAVN) | Purchase | 46,337 | $839.2K |
| Jan 6, 2026 | Navan, Inc. (NAVN) | Purchase | 466,058 | $7.58M |
| Dec 29, 2025 | Navan, Inc. (NAVN) | Purchase | 334,112 | $5.31M |
| Dec 20, 2025 | Navan, Inc. (NAVN) | Purchase | 347,600 | $4.40M |